3,0
2. Juni 2022
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great R&D sites and facilities, passionate people, many carreer opportunities
Kontras
Style over substance, no clear direction or long-term vision, leadership has huge ambitions but does not create an environment where real innovation can happen. The "Cool Science" strategy and terrible "new modalities" pipeline encourages scientists to focus on their publication records instead of bringing new medicines to the clinic